Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_assertion type Assertion NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_head.
- NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_provenance.
- NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_assertion evidence source_evidence_literature NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_provenance.
- NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_assertion SIO_000772 7571088 NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_provenance.
- NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_assertion wasDerivedFrom befree-20140225 NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_provenance.
- NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_assertion wasGeneratedBy ECO_0000203 NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_provenance.